Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Teva Generics Company Intelligence Report' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Teva Generics Company Intelligence Report Company Intelligence Report |
March 2009 | £195 | 99 % |
|
Teva Pharmaceutical Industries Generics Company Intelligence Report |
June 2008 | £195 | 97 % |
|
Teva Pharmaceutical Industries - SWOT Analysis |
October 2008 | £66 | 49.5 % |
|
Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in The Face of Growing Generic Competition |
July 2008 | £3800 | 35 % |
|
Biosimilars: a viable market? |
September 2008 | £1295 | 25.2 % |
|
The Outlook for Pharmaceuticals in Central & Eastern Europe |
March 2007 | £1995 | 18.5 % |
